Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine

Powder-injectors use gas propulsion to deposit lyophilised drug or vaccine particles in the epidermal and sub epidermal layers of the skin. We prepared dry-powder (Tg = 45.2 ± 0.5°C) microparticles (58.1 μm) of a MenY-CRM197 glyconjugate vaccine (0.5% wt.) for intradermal needle-free powder injectio...

Descripció completa

Dades bibliogràfiques
Autors principals:	Weissmueller, N, Marsay, L, Schiffter, H, Carlisle, R, Rollier, C, Prud'homme, R, Pollard, A
Format:	Journal article
Idioma:	English
Publicat:	Public Library of Science 2017

Ítems similars

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine.
per: Nikolas T Weissmueller, et al.
Publicat: (2017-01-01)

Needle-free dermal delivery of a diphtheria toxin CRM197 mutant on potassium-doped hydroxyapatite microparticles
per: Weissmueller, N, et al.
Publicat: (2015)

Intradermal powder immunization with protein-containing vaccines.
per: Weissmueller, N, et al.
Publicat: (2013)

Recent advances in lipopolysaccharide-based glycoconjugate vaccines
per: Zhu, H, et al.
Publicat: (2021)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
per: Snape, MD, et al.
Publicat: (2009)

Needle-free vaccination: formulation and dermal delivery of diphtheria toxin CRM197 mutant
per: Weissmueller, NT
Publicat: (2013)

The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
per: Rollier, C, et al.
Publicat: (2014)

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
per: Perrett, K, et al.
Publicat: (2009)

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
per: Micoli, F, et al.
Publicat: (2013)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
per: Snape, MD, et al.
Publicat: (2008)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
per: Read, R, et al.
Publicat: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
per: Read, R, et al.
Publicat: (2014)

Meningococcal vaccines.
per: Rüggeberg, J, et al.
Publicat: (2004)

Meningococcal vaccines.
per: Collins, C, et al.
Publicat: (2002)

Meningococcal vaccines.
per: Bethell, D, et al.
Publicat: (2002)

Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy
per: Pace, D, et al.
Publicat: (2016)

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease
per: Dold, C, et al.
Publicat: (2023)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
per: Snape, MD, et al.
Publicat: (2006)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
per: Snape, M, et al.
Publicat: (2006)

Vaccines for prevention of meningococcal disease.
per: Pollard, A, et al.
Publicat: (2000)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
per: Sachin Shivatare, et al.
Publicat: (2022-08-01)

Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines
per: MacLennan, C, et al.
Publicat: (2016)

Quadrivalent meningococcal conjugate vaccines
per: Pace, D, et al.
Publicat: (2009)

Quadrivalent meningococcal conjugate vaccines.
per: Pace, D, et al.
Publicat: (2009)

Meningococcal disease and vaccination in North America.
per: Pollard, A, et al.
Publicat: (2001)

Reconsideration of the use of meningococcal polysaccharide vaccine.
per: Granoff, D, et al.
Publicat: (2007)

The epidemiology of meningococcal disease and the impact of vaccines.
per: Khatami, A, et al.
Publicat: (2010)

Meningococcal polysaccharide-protein conjugate vaccines.
per: Snape, MD, et al.
Publicat: (2005)

Global epidemiology of meningococcal disease and vaccine efficacy
per: Pollard, A
Publicat: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy.
per: Pollard, A
Publicat: (2004)

Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
per: Johanna Hettinga, et al.
Publicat: (2020-09-01)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial
per: Rollier, CS, et al.
Publicat: (2022)

The next chapter for group B meningococcal vaccines
per: Wang, N, et al.
Publicat: (2017)

Group B meningococcal vaccine science and policy
per: Drysdale, SB, et al.
Publicat: (2015)

Serogroup B meningococcal vaccines-an unfinished story.
per: Sadarangani, M, et al.
Publicat: (2010)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
per: Giuseppe Stefanetti, et al.
Publicat: (2022-09-01)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
per: Robert M.F. van der Put, et al.
Publicat: (2023-01-01)

Glycoconjugate vaccines against antimicrobial resistant pathogens
per: Charlotte Sorieul, et al.
Publicat: (2023-12-01)